Canada Life
GMAB icon

Canada Life’s Genmab GMAB Stock Holding History

Canada Life’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$163K Sell
5,944
-317
-5% -$8.43K ﹤0.01% 1615
2026
Q1 		$168K Buy
6,261
+1,739
+38% +$52.1K ﹤0.01% 1621
2025
Q4 		$139K Buy
4,522
+1,369
+43% +$42.7K ﹤0.01% 1677
2025
Q3 		$92K Buy
3,153
+627
+25% +$15.3K ﹤0.01% 1769
2025
Q2 		$52K Buy
2,526
+262
+12% +$5.38K ﹤0.01% 1828
2025
Q1 		$44K Buy
2,264
+697
+44% +$14.6K ﹤0.01% 1871
2024
Q4 		$33K Sell
1,567
-1,143
-42% -$25.1K ﹤0.01% 1917
2024
Q3 		$66K Buy
2,710
+838
+45% +$22.4K ﹤0.01% 1913
2024
Q2 		$47K Buy
1,872
+891
+91% +$25.3K ﹤0.01% 1973
2024
Q1 		$29K Buy
981
+281
+40% +$8.26K ﹤0.01% 2056
2023
Q4 		$22K Sell
700
-244
-26% -$7.66K ﹤0.01% 2092
2023
Q3 		$33K Buy
944
+9
+1% +$343 ﹤0.01% 2082
2023
Q2 		$36K Sell
935
-655
-41% -$26.1K ﹤0.01% 2042
2023
Q1 		$60K Buy
1,590
+649
+69% +$24.9K ﹤0.01% 2041
2022
Q4 		$40K Buy
941
+141
+18% +$5.81K ﹤0.01% 2122
2022
Q3 		$26K Buy
800
+206
+35% +$7.23K ﹤0.01% 2214
2022
Q2 		$19K Buy
594
+198
+50% +$6.42K ﹤0.01% 2276
2022
Q1 		$15K Buy
396
+201
+103% +$6.9K ﹤0.01% 2397
2021
Q4 		$8K Buy
+195
New +$8.13K ﹤0.01% 2457

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Canada Life's GMAB Position: Q2 2026 in Review

Canada Life reduced its Genmab (GMAB) stake by 5.1% in Q2 2026, selling an estimated $8.43K and leaving 5,944 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #1615.

Canada Life first reported a position in GMAB in Q4 2021 and has held it in 19 quarters since. The position peaked at $168K in Q1 2026. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Canada Life held 5,944 shares of Genmab worth $163K as of Q2 2026.
  • Canada Life sold 317 Genmab shares in Q2 2026, an estimated $8.43K.
  • Genmab made up ﹤0.01% of Canada Life's portfolio in Q2 2026, its #1615 holding.
  • Canada Life first reported a position in Genmab in Q4 2021 and has held it in 19 quarters since.
  • Canada Life's Genmab position peaked at $168K in Q1 2026.
  • 291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Canada Life's 13F filing for Q2 2026, filed 13 Aug 2026.